Company intelligence / Profile preview

Cardihab

Brisbane, Queensland, Australia

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Cardihab's randomized controlled trial demonstrated significantly higher uptake (80% vs 62%), adherence (94% vs 68%), and completion rates (80% vs 47%) compared to traditional hospital-based cardiac rehabilitation. The platform also showed reduced anxiety and psychological distress, with significant improvements to health-related quality of life[4][5]. A separate clinical study found that offering Cardihab increased participation rates from 21% to 63% when provided as an alternative to conventional in-person programs, with an observed 4% readmission rate[5].

Therapeutic areas: Cardiovascular
Modalities: Digital therapeutic platformSoftware as a service (SaaS)
Industry: Digital Health Medical Devices

Partnerships

Roche DiagnosticsBupa (private health insurer)Mater Health ServicesHeart Support AustraliaAlbury Wodonga Health

Beyond the preview

Go deeper on Cardihab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardihab.

Explore the full profile